BEAT News and Press, Heartbeam Inc. From 05/31/23

2023-05-31 08:32:12 ET Belite Bio ( BLTE ) -37% commences public offering of American Depositary Shares of $30M. Advance Auto Parts ( AAP ) -27% after Q1 earning release . Ambarella ( AMBA ) -20% after Q1 earning release . FG Financial Group (FG...

2023-05-30 10:01:01 ET Gainers: HeartBeam ( BEAT ) +23% . Taro Pharmaceutical Industries ( TARO ) +22% . Akebia Therapeutics ( AKBA ) +19% . Corvus Pharmaceuticals ( CRVS ) +16% . Immix Biopharma ( IMMX ) +13% . Losers:...

2023-05-30 09:03:45 ET HeartBeam ( NASDAQ: BEAT ) is trading 35% higher premarket after it had entered into a strategic alliance with Samsung to revolutionize cardiac diagnostics. The partnership combines HeartBeam's expertise in cardiac assessment and monitoring with Sams...

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA...

2023-05-25 10:04:19 ET Gainers: Absci ( ABSI ) +17% . Predictive Oncology ( POAI ) +10% . Cardio Diagnostics ( CDIO ) +8% . Ocean Biomedical ( OCEA ) +8% . HeartBeam ( BEAT ) +7% . Losers: Annexon ( ANNX ) -57% .&#...

Patent Underscores AI for Vectorcardiography (VECG) IP Leadership Effort HeartBeam, Inc . (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for patient use at home, today announced it has received ...

HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only 3D vector electrocardiogram (“VECG”) platform intended for patient use at home, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (“FDA&#...

2023-05-18 09:11:02 ET HeartBeam ( NASDAQ: BEAT ) has submitted a marketing application to the FDA for its HeartBeam AIMIGo System. The AIMIGo System is a personal, portable VECG solution for assessing cardiac symptoms. It utilizes a reusable VECG recording device and clou...

Submission Seeks Clearance for the Company’s 3D Vector Electrocardiogram Device HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for patient use at home, today announced it ...

2023-05-14 05:21:09 ET HeartBeam, Inc. (BEAT) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Rob Eno - President Richard Brounstein - Chief Financial Officer Conference C...